Cargando…
Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity
Steatosis is a liver lesion reported with numerous pharmaceuticals. Prior studies showed that severe impairment of mitochondrial fatty acid oxidation (mtFAO) constantly leads to lipid accretion in liver. However, much less is known about the mechanism(s) of drug-induced steatosis in the absence of s...
Autores principales: | Allard, Julien, Bucher, Simon, Massart, Julie, Ferron, Pierre-Jean, Le Guillou, Dounia, Loyant, Roxane, Daniel, Yoann, Launay, Youenn, Buron, Nelly, Begriche, Karima, Borgne-Sanchez, Annie, Fromenty, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012331/ https://www.ncbi.nlm.nih.gov/pubmed/32535746 http://dx.doi.org/10.1007/s10565-020-09537-1 |
Ejemplares similares
-
Evaluation of the impact of matrix stiffness on encapsulated HepaRG spheroids
por: Rebelo, Sofia P, et al.
Publicado: (2013) -
Evaluation of a novel PXR‐knockout in HepaRG(™) cells
por: Williamson, Beth, et al.
Publicado: (2016) -
Active Transport of Hepatotoxic Pyrrolizidine Alkaloids in HepaRG Cells
por: Enge, Anne-Margarethe, et al.
Publicado: (2021) -
Transcriptional and Epigenetic Consequences of DMSO Treatment on HepaRG Cells
por: Dubois-Pot-Schneider, Hélène, et al.
Publicado: (2022) -
Okadaic acid influences xenobiotic metabolism in HepaRG cells
por: Wuerger, Leonie T.D., et al.
Publicado: (2022)